Binge Eating Disorder
📧 Sign up to get email alerts when something new happens for Binge Eating Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Dialectical Behavioral Therapy As A Therapeutic Tool In Patients With Binge Eating Disorder [Phase 4]
A Phase 4 clinical trial evaluating dialectical behavior therapy as a treatment for binge eating disorder has completed.
-
FDA approval · 2025-01-29FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals' lisdexamfetamine dimesylate as a generic drug (Original Application) with indications for attention-d…
-
FDA approval · 2025-01-23FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for lisdexamfetamine dimesylate from Camber Pharmaceuticals, enabling its generic product to be …
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Neuromodulation with Attention Bias Modification Training for Binge Eating Disorder [NA]
This document reports the completion of a clinical trial evaluating neuromodulation combined with attention bias modification training for b…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Binge Eating Syndrome Treatment for Older Women (BESTOW) [NA]
The BESTOW trial evaluating treatment for binge eating disorder in older women has completed and posted results. Sponsor: The University of …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: A Longitudinal Study of Severe and Enduring Eating Disorders
A longitudinal clinical trial update about a study recruiting participants with severe and enduring eating disorders, including anorexia ner…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: A Pilot Study of Evidence-based Guided Self-help for the Treatment of Binge Eating [NA]
A pilot study assessing an evidence-based guided self-help approach for treating binge eating has been completed.
-
FDA approval · 2024-12-17FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (SpecGx LLC)
FDA approved lisdexamfetamine dimesylate as a generic version of Vyvanse under an Original Application (ANDA) from SpecGx LLC. The product i…
-
FDA approval · 2024-12-16FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s original application for lisdexamfetamine dimesylate, a generic version of the ADHD medication,…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Multimodal Longitudinal and Predictive Modelling to Understand Eating Disorder Development
A completed clinical trial from King's College London studying multimodal longitudinal and predictive modeling to understand the development…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Evaluation of Pilot Online Binge Eating Disorder Group (BEG) in Under 18s.
A completed clinical trial evaluating a pilot online group therapy for binge eating disorder in individuals under 18.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder [Phase 2]
Phase 2 clinical trial evaluating TRP-8802 (psilocybin) for binge eating disorder has completed.
-
FDA approval · 2024-11-15FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Elite Laboratories, Inc.)
FDA approved the original application for lisdexamfetamine dimesylate as a generic product from Elite Laboratories, Inc., confirming regulat…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: EMOTE: a Smartphone Application for Binge Eating Based on DBT Skills [NA]
EMOTE is a smartphone application that uses Dialectical Behavior Therapy skills to address binge eating and is currently recruiting for the …
-
CLINICAL_TRIALS withdrawal · 2024-10-31Clinical Trial Update: A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders [Phase 2]
A Phase 2 multi-site trial of MDMA-assisted psychotherapy for eating disorders has been withdrawn from recruitment.
-
FDA approval · 2024-10-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for lisdexamfetamine dimesylate (ANDA 217068), allowing marketing of a generic…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment [Phase 3]
Phase 3 trial evaluating cognitive-behavioral therapy in combination with lisdexamfetamine (LDX) for binge-eating disorder and obesity has c…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Evaluating the Feasibility of a Stepped-care Approach to Treating Adolescents With Binge and Loss of Control Eating [NA]
A clinical trial from Virginia Commonwealth University evaluated a stepped-care approach to treating adolescents with binge eating and loss …
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating [NA]
A clinical trial tested cognitive behavioral therapy for adolescents with binge eating and loss of control eating; results have been posted.
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: Compuls-BED-Severity
A Laval University-sponsored clinical trial called Compuls-BED-Severity for binge-eating disorder is currently recruiting.
-
FDA approval · 2024-09-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for lisdexamfetamine dimesylate (generic) submitted by SpecGx LLC under ANDA 211840.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: The Effects of Heart Rate Variability Biofeedback on College Students With Disordered Eating [NA]
A completed study from Arizona State University evaluating heart rate variability biofeedback in college students with disordered eating to …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Unfolding Severe and Enduring Eating Disorders (U-SEED)
Clinical Trial Update: U-SEED is a study at Uppsala University Hospital investigating severe and enduring eating disorders and is currently …
-
FDA approval · 2024-09-16FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application to market lisdexamfetamine dimesylate as a generic drug, expanding access…
-
FDA approval · 2024-09-16FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
The FDA approved a supplemental application for lisdexamfetamine dimesylate from Teva Pharmaceuticals under an ANDA, approving changes to th…